$1.76
+0.12 (6.86%)
Citius Oncology, Inc. Common Stock (CTOR)
Citius Oncology, Inc. (CTOR) is a biopharmaceutical company focused on developing targeted cancer therapies. The company aims to advance innovative treatments by leveraging immunology and oncology research to improve outcomes for cancer patients.
Company News
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Citius Oncology closed a $9.0 million registered direct offering and private placement, issuing 5,142,858 shares of common stock and accompanying warrants at $1.75 per share, with warrants exercisable at $1.84 per share.